Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
David Rosmarin, Amit G. Pandya, Mark Lebwohl, Pearl E. Grimes, Iltefat Hamzavi, Alice B. Gottlieb, Kathleen Butler, Fiona Kuo, Kang Sun, Tao Ji, Michael Howell, John E. Harris
Topics & Concepts
VitiligoMedicineDepigmentationRuxolitinibClinical trialQuality of life (healthcare)Randomized controlled trialDermatologyBody surface areaInternal medicineBone marrowNursingMyelofibrosismelanin and skin pigmentationMast cells and histamineGlaucoma and retinal disorders